Drug addiction and substance abuse – social and health impact MCQs With Answer

Drug addiction and substance abuse present complex social and health challenges that B. Pharm students must understand. This topic covers neurobiology of dependence, pharmacology of commonly abused substances, clinical features of intoxication and withdrawal, evidence-based treatments (agonists, antagonists, detoxification), harm reduction, rehabilitation strategies, public health implications, and legal/ethical issues. Knowledge of screening tools, pharmacotherapy (methadone, buprenorphine, naltrexone, disulfiram, acamprosate, naloxone), comorbidities (HIV, hepatitis, mental illness), and prevention policies is essential for future pharmacists involved in patient counseling, medication management, and community programs. These MCQs emphasize clinical decision-making, adverse drug interactions, dosing, monitoring, and public health interventions to prepare you for examinations and pharmacy practice. Now let’s test your knowledge with 30 MCQs on this topic.

Q1. Which term does the DSM-5 use to describe the spectrum of problematic substance use?

  • Substance dependence
  • Substance abuse
  • Substance use disorder
  • Substance intoxication

Correct Answer: Substance use disorder

Q2. Which neurotransmitter is most closely associated with the brain reward pathway involved in addiction?

  • Serotonin
  • Dopamine
  • GABA
  • Acetylcholine

Correct Answer: Dopamine

Q3. What is the immediate antidote for opioid overdose used in emergency settings?

  • Naltrexone
  • Flumazenil
  • Naloxone
  • Atropine

Correct Answer: Naloxone

Q4. Methadone used in opioid substitution therapy acts primarily as:

  • A competitive opioid antagonist
  • A partial μ-opioid receptor agonist
  • A long-acting full μ-opioid receptor agonist
  • A monoamine oxidase inhibitor

Correct Answer: A long-acting full μ-opioid receptor agonist

Q5. Buprenorphine’s pharmacologic profile is best described as:

  • Full μ-opioid receptor agonist and κ-agonist
  • Partial μ-opioid receptor agonist and κ-opioid receptor antagonist
  • Pure opioid antagonist
  • NMDA receptor antagonist

Correct Answer: Partial μ-opioid receptor agonist and κ-opioid receptor antagonist

Q6. Naltrexone is indicated in the management of which conditions?

  • Opioid dependence only
  • Alcohol dependence only
  • Both opioid and alcohol dependence as an opioid receptor antagonist
  • Benzodiazepine overdose

Correct Answer: Both opioid and alcohol dependence as an opioid receptor antagonist

Q7. The most serious acute complication of alcohol withdrawal, characterized by confusion, autonomic instability, and hallucinations, is:

  • Wernicke’s encephalopathy
  • Korsakoff’s syndrome
  • Delirium tremens
  • Hepatic encephalopathy

Correct Answer: Delirium tremens

Q8. Which medication has the strongest evidence to reduce heavy drinking days in alcohol use disorder?

  • Disulfiram
  • Acamprosate
  • Naltrexone
  • Benzodiazepines

Correct Answer: Naltrexone

Q9. Disulfiram reduces alcohol consumption by inhibiting which enzyme?

  • Alcohol dehydrogenase
  • Aldehyde dehydrogenase
  • Monoamine oxidase
  • Cytochrome P450 2E1

Correct Answer: Aldehyde dehydrogenase

Q10. The AUDIT screening tool is designed to detect which condition?

  • Depression severity
  • Alcohol Use Disorders Identification Test
  • Drug dependence screening
  • Hepatitis risk assessment

Correct Answer: Alcohol Use Disorders Identification Test

Q11. Tolerance in substance use is best defined as:

  • A persistent craving despite abstinence
  • A decreased effect from the same dose over time
  • An immediate allergic reaction to a drug
  • A cognitive impairment caused by intoxication

Correct Answer: A decreased effect from the same dose over time

Q12. Pharmacological dependence differs from addiction in that dependence primarily reflects:

  • Compulsive drug-seeking behavior
  • Physiological adaptation and withdrawal on cessation
  • Criminal activity related to drug use
  • Social isolation due to substance use

Correct Answer: Physiological adaptation and withdrawal on cessation

Q13. Which harm reduction intervention most directly reduces blood-borne infection transmission among people who inject drugs?

  • Criminalizing drug possession
  • Needle and syringe exchange programs
  • Compulsory inpatient treatment
  • Public awareness posters

Correct Answer: Needle and syringe exchange programs

Q14. Which psychiatric disorder commonly co-occurs with substance use disorders and complicates treatment?

  • Osteoporosis
  • Major depressive disorder
  • Rheumatoid arthritis
  • Myopia

Correct Answer: Major depressive disorder

Q15. Clonidine can be used in opioid withdrawal because it:

  • Is a full opioid agonist that replaces heroin
  • Stimulates dopamine release in the nucleus accumbens
  • Is an α2-adrenergic agonist that reduces noradrenergic hyperactivity
  • Blocks NMDA receptors to reduce cravings

Correct Answer: Is an α2-adrenergic agonist that reduces noradrenergic hyperactivity

Q16. Which medication used in opioid maintenance therapy is associated with QT interval prolongation?

  • Methadone
  • Buprenorphine
  • Naloxone
  • Naltrexone

Correct Answer: Methadone

Q17. The specific antagonist used for benzodiazepine overdose in selected patients is:

  • Naloxone
  • Flumazenil
  • Physostigmine
  • Propranolol

Correct Answer: Flumazenil

Q18. A sensitive biomarker for chronic heavy alcohol consumption is:

  • Carbohydrate-deficient transferrin (CDT)
  • C-reactive protein (CRP)
  • Serum creatinine
  • Erythrocyte sedimentation rate (ESR)

Correct Answer: Carbohydrate-deficient transferrin (CDT)

Q19. Chronic heavy alcohol use most commonly causes long-term damage to which organ?

  • Lungs
  • Liver
  • Pancreas only
  • Skin

Correct Answer: Liver

Q20. Which vaccine is especially recommended for people who inject drugs to reduce long-term morbidity?

  • HPV vaccine
  • Influenza vaccine
  • Hepatitis B vaccine
  • Measles vaccine

Correct Answer: Hepatitis B vaccine

Q21. Naloxone reverses opioid effects by acting as a:

  • Non-competitive opioid receptor agonist
  • Uncompetitive NMDA antagonist
  • Competitive opioid receptor antagonist
  • GABA receptor agonist

Correct Answer: Competitive opioid receptor antagonist

Q22. Nicotine replacement therapy aids smoking cessation primarily by:

  • Blocking nicotinic receptors permanently
  • Providing controlled nicotine to reduce withdrawal
  • Inhibiting dopamine reuptake
  • Acting as a serotonin agonist

Correct Answer: Providing controlled nicotine to reduce withdrawal

Q23. Bupropion facilitates smoking cessation through which mechanism?

  • Partial nicotinic receptor agonism
  • Norepinephrine-dopamine reuptake inhibition (NDRI)
  • Monoamine oxidase inhibition
  • GABA potentiation

Correct Answer: Norepinephrine-dopamine reuptake inhibition (NDRI)

Q24. Varenicline’s action in smoking cessation is best described as:

  • A full agonist at α4β2 nicotinic receptors
  • A dopamine receptor antagonist
  • A partial agonist at α4β2 nicotinic receptors
  • A monoamine oxidase inhibitor

Correct Answer: A partial agonist at α4β2 nicotinic receptors

Q25. Which behavior in substance users most directly increases risk of HIV and hepatitis C transmission?

  • Oral ingestion of alcohol
  • Sharing injection equipment
  • Smoking cannabis
  • Using transdermal patches

Correct Answer: Sharing injection equipment

Q26. Chronic cocaine use is particularly associated with which cardiovascular risk?

  • Coronary vasospasm leading to myocardial infarction
  • Primary pulmonary fibrosis
  • Progressive peripheral neuropathy only
  • Hyperkalemia

Correct Answer: Coronary vasospasm leading to myocardial infarction

Q27. Motivational interviewing in addiction treatment is primarily intended to:

  • Confront and shame the patient into abstinence
  • Enhance intrinsic motivation by exploring ambivalence
  • Provide medication directly without counseling
  • Enforce mandatory treatment compliance

Correct Answer: Enhance intrinsic motivation by exploring ambivalence

Q28. Combining opioid substitution therapy with benzodiazepines increases risk of:

  • Hypertension
  • Respiratory depression and fatal overdose
  • Seizure protection
  • Improved cognitive function

Correct Answer: Respiratory depression and fatal overdose

Q29. Co-use of alcohol with which class of drugs most increases risk of fatal CNS depression?

  • Benzodiazepines
  • Stimulants
  • Hallucinogens
  • SSRIs

Correct Answer: Benzodiazepines

Q30. A proven public health intervention to reduce opioid overdose deaths in communities is:

  • Distributing take-home naloxone and training bystanders
  • Only increasing prison sentences for users
  • Banning opioid substitution therapies
  • Prohibiting all opioid prescriptions

Correct Answer: Distributing take-home naloxone and training bystanders

Author

  • G S Sachin
    : Author

    G S Sachin is a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. He holds a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research and creates clear, accurate educational content on pharmacology, drug mechanisms of action, pharmacist learning, and GPAT exam preparation.

    Mail- Sachin@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators